Active Pharmaceutical Ingredientia
Progestogen et Estrogen | |||
Product Name | Specification | Probatus | CAS Non. |
Progesterone | CP/EP/USP | CEP/EU-GMP/FDA | 57-83-0 |
Pregnenolone | In domo |
Kosher | 145-13-1 |
Medroxyprogesterone Acetate | CP/EP/USP | DMF/GMP | 71-58-9 |
Megestrol acetate | CP/EP/USP | DMF in processusususus | 595-33-5 |
Mifepristone | CP/IP | DMF/GMP | 84371-65-3 |
Cyproterone Acetate | CP/EP | CEP/TGA/EU-GMP | 427-51-0 |
Levonorgestrel | CP/EP/USP | CEP/GMP | 797-63-7 |
Drospirenone | EP/USP | DMF | 67392-87-4 |
Gestodene | CP/EP | DMF/GMP | 60282-87-3 |
Estradiol | CP/EP/USP | DMF/GMP | 35380-71-3 |
Estriol | CP/EP/USP | Sub R&D | 50-27- 1 |
Ethinyl Estradiol | CP/EP/USP | GMP | 57-63-6 |
Estradiol Valerate | CP | DMF | 979-32-8 |
Tibolone | CP/EP | DMF/GMP | 5630-53-5 |
Dienogest | EP | CEP | 65928-58-7 |
Fulvestrant | In domo | Sub R&D | 129453-61-8 |
Exemestane | EP/USP | Sub R&D | 107868-30-4 |
Androgen | |||
Product Name | Specification | Probatus | CAS Non. |
Finasteride | CP/EP/USP | CEP/FDA/PMDA/GMP | 98319-26-7 |
Dutasteride | EP/USP | CEP/FDA | 164656-23-9 |
Abiraterone Acetate | CP/USP | DMF/WC | 154229-18-2 |
Testosterone | CP/EP/USP | CEP/WC/FDA | 58-22-0 |
Testosterone Undecanoate | CP | DMF/WC | 5949-44-0 |
Testosterone Cypionate | USP | Sub R&D | 58-20-8 |
DHEA(Prasterone) | FP/In domo | DMF/WC/Kosher | 53-43-0 |
Clascoterone | In domo | DMF in processusususus | 19608-29-8 |
Cortical Hormone | |||
Product Name | Specification | Probatus | CAS Non. |
Budesonide | CP/EP/USP | CEP/FDA/GMP | 51333-22-3 |
Desonide | USP | DMF/GMP | 638-94-8 |
Eplerenone | EP | CEP in processu | 107724-20-9 |
Methylprednisolone | CP/EP/USP | DMF/GMP | 83-43-2 |
Methylprednisolone Hemisuccinate | CP/EP/USP | DMF/GMP | 2921-57-5 |
Fluticasone Propionate | CP/EP/USP | DMF | 80474- 14-2 |
Fluticasone Furoate | In domo | DMF in processusususus | 397864-44-7 |
Mometasone Furoate |
EP/USP |
DMF in processusususus |
Anhydrous (83919-23-7) Monohydratorum (141646-00-6) |
alii | |||
Product Name | Specification | Probatus | CAS Non. |
Oxcarbazepine | CP/EP/USP | CEP/FDA | 28721-07-5 |
Eslicarbazepine Acetate | In domo | DMF | 236395- 14-5 |
Ganciclovir | CP/EP/USP | DMF/GMP | 82410-32-0 |
Valganciclovir Hydrochloride | USP | DMF | 175865-59-5 |
Oseltamivir Phosphate | CP/EP/USP | DMF | 204255- 11-8 |
Baloxavir Marboxil | In domo | Sub R&D | 1985606-14-1 |
Nintedanib Esylate | In domo | DMF/FDA | 656247-18-6 |
Revefenacin | In domo | DMF | 864750-70-9 |
Mirabegron | In domo | DMF | 223673-61-8 |
Escitalopram Oxalate | EP/USP/CP | DMF in processususus | 219861-08-2 |
Cariprazine hydrochloride | In domo | DMF | 1083076-69-0 |
Lasmiditan Succinate | In domo | DMF | 439239-92-6 |
Iuliconazole | In domo | DMF | 187164-19-8 |
Apalutami | In domo | DMF in processususus | 956104-40-8 |
Tadalafil | EP/USP/CP | Sub R&D | 171596-29-5 |
Relugolix | In domo | DMF in processususus | 737789-87-6 |
Phloroglucinol | CP | DMF | 108-73-6 |
Acidum Ursodeoxycholic | EP/USP/JP | Sub R&D | 128-13-2 |
Omega-3-Acid Ethyl Ethers 90 |
EP/USP |
DMF in processusususus |
-- |
Medium-Chain Triglycerides |
CP/USP/EP |
DMF |
-- |
Benzalkonium Chloride |
USP/EP/JP |
CEP in processu |
8001-54-5 |
Oleum olivae (For Iniectio) |
CP/USP/EP/JP |
DMF in processusususus |
8001-25-0 |
Ovum phospholipids (Nam Iniectio) |
CP/USP/EP |
DMF |
93685-90-6 |
PORTIO |
In domo |
DMF in processusususus |
203787-91-1 |
Testosterone CP, EP et USP specificationes habet. CEP, DMF, WC, FDA in promptu sunt.
Testosterone undecanoatus CP specificationem habet. TP in promptu et DMF sub interpositione.
Testosteronus cypionatus USP specificationem habet.TP praesto et DMF sub interpositione.
DHEA (Prasterone) habet FP et In-domus specification.DMF et WC in promptu.
Gestodenus habet CP et EP specificationem. DMF, GMP available.
Ethinyl Estradiol habet USP, EP et CP specifications.DMF et GMP in promptu.